Sun Pharmaceutical Industries Ltd Share Price Today - Live Blog for February 19, 2026

Sun Pharmaceutical Industries Ltd witnessed a -0.37% decrease in its share price, and it is currently trading at 1718.00. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 37.7700, an ROE of 14.8407 and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.37%, a situation worth noting. At present, the stock is trading at 1718.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 37.7700, while the industry PE ratio is 32.0206.

Sun Pharmaceutical Industries Ltd observed a -0.15% decrease in its share price, a situation that merits attention. As of now, it's actively trading at 1721.80. The stock has a PE ratio of 37.7700, an ROE of 14.8407 and a debt to equity ratio of 0.0670.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.15% in its share price, and it currently trades at 1721.80 per share. The stock has an ROE of 14.8407 and debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd shares experienced a -0.18% reduction, with the current market price at 1721.30. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.18%, leaving investors concerned. At this moment, the stock can be acquired at 1721.30, but investors are assessing whether this is a temporary dip or a long-term trend.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.05% in its share price, and it currently trades at 1723.50 per share. The stock has an ROE of 14.8407 and debt to equity ratio of 0.0670.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.05% in its share price, and it currently trades at 1723.50 per share. The stock has an ROE of 14.8407 and debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd experienced a -0.21% dip in its share price and is currently trading at 1720.80. The stock has a PE ratio of 37.7700, an ROE of 14.8407 and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.21%, presenting both challenges and opportunities for investors. As of now, it's trading at 1720.80, and market participants are assessing the implications. The stock has a PE ratio of 37.7700, an ROE of 14.8407 and a debt to equity ratio of 0.0670.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.05%, signalling a challenging period. Currently trading at 1723.60, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.05%, reaching a current market price of 1723.60. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.